Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 2/20 | 0.63 |
| ▸ | GHSR | Q92847 | 2/20 | 0.59 |
| ▸ | GPR183 | P32249 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | FASN | P49327 | 1/20 | 0.55 |
| ▸ | DRD2 | P14416 | 1/20 | 0.55 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
| ▸ | MGLL | Q99685 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | GFER | P55789 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | NUDT15 | Q9NV35 | 1/20 | 0.52 |
| ▸ | OXTR | P30559 | 1/20 | 0.51 |
| ▸ | CCR3 | P51677 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3457123 | 1.00 | MAPK14 (0.63) | MAPK14GHSRGPR183LMNAALDH1A1 | |
| SCHEMBL29944365 | 1.00 | MAPK14 (0.63) | MAPK14GHSRGPR183LMNAALDH1A1 | |
| SCHEMBL8534513 | 0.98 | MAPK14 (0.64) | MAPK14GHSRGPR183LMNAALDH1A1 | |
| SCHEMBL30226931 | 0.98 | MAPK14 (0.64) | MAPK14GHSRGPR183LMNAALDH1A1 | |
| SCHEMBL30329646 | 0.95 | MAPK14 (0.64) | MAPK14GHSRGPR183LMNAFASN | |
| SCHEMBL22216445 | 0.95 | MAPK14 (0.64) | MAPK14GHSRGPR183LMNAFASN | |
| SCHEMBL29944074 | 0.89 | GHSR (0.71) | MAPK14GHSRALDH1A1HPGDNPC1 | |
| SCHEMBL1355458 | 0.89 | GHSR (0.71) | MAPK14GHSRALDH1A1HPGDNPC1 | |
| SCHEMBL3386763 | 0.87 | MAPK14 (0.62) | MAPK14GHSRGPR183FASNDRD2 | |
| SCHEMBL30066210 | 0.87 | MAPK14 (0.62) | MAPK14GHSRGPR183FASNDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11345702-B1 | PGDH inhibitors and methods of making and using | MYOFORTE THERAPEUTICS, INC. (US) | 2022-05-31 | — | — | US | disclosed |
| WO-2022082009-A1 | INHALED FORMULATIONS OF PGDH INHIBITORS AND METHODS OF USE THEREOF | EPIRIUM BIO INC. (US) | 2022-04-21 | — | — | WO | disclosed |
| US-11052377-B2 | Supported metal catalyst | TOYO GOSEI CO., LTD. (JP) | 2021-07-06 | — | — | US | disclosed |
| US-20200290018-A1 | SUPPORTED METAL CATALYST | TOYO GOSEI CO., LTD. (JP) | 2020-09-17 | — | — | US | disclosed |
| EP-2811990-B1 | MODULATORS OF EXCHANGE PROTEINS DIRECTLY ACTIVATED BY CAMP (EPACS) | UNIV TEXAS (US) | 2017-10-25 | — | — | EP | disclosed |
| US-9539256-B2 | Modulators of exchange proteins directly activated by cAMP (EPACS) | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2017-01-10 | — | — | US | disclosed |
| US-9539256-B2 | Modulators of exchange proteins directly activated by cAMP (EPACS) | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2017-01-10 | — | — | US | disclosed |
| US-9539256-B2 | Modulators of exchange proteins directly activated by cAMP (EPACS) | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2017-01-10 | — | — | US | disclosed |
| US-9328125-B2 | Bivalent AMPA receptor positive allosteric modulators | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2016-05-03 | — | — | US | disclosed |
| US-9328125-B2 | Bivalent AMPA receptor positive allosteric modulators | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2016-05-03 | — | — | US | disclosed |
| US-20150110809-A1 | MODULATORS OF EXCHANGE PROTEINS DIRECTLY ACTIVATED BY CAMP (EPACS) | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-04-23 | — | — | US | disclosed |
| US-20150110809-A1 | MODULATORS OF EXCHANGE PROTEINS DIRECTLY ACTIVATED BY CAMP (EPACS) | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-04-23 | — | — | US | disclosed |
| US-20150057248-A1 | BIVALENT AMPA RECEPTOR POSITIVE ALLOSTERIC MODULATORS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-02-26 | — | — | US | disclosed |
| US-20150057248-A1 | BIVALENT AMPA RECEPTOR POSITIVE ALLOSTERIC MODULATORS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-02-26 | — | — | US | disclosed |
| WO-2013130501-A1 | BIVALENT AMPA RECEPTOR POSITIVE ALLOSTERIC MODULATORS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-09-06 | — | — | WO | disclosed |
| WO-2013119931-A1 | MODULATORS OF EXCHANGE PROTEINS DIRECTLY ACTIVATED BY CAMP (EPACS) | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-08-15 | — | — | WO | disclosed |
| US-20110178062-A1 | INDOLE AND BENZOTHIOPHENE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR | JANSSEN PHARMACEUTICA N.V. (BE) | 2011-07-21 | — | — | US | disclosed |
| EP-2125720-A1 | INDOLE AND BENZOTHIOPHENE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR | Janssen Pharmaceutica, N.V. (BE) | 2009-12-02 | — | — | EP | disclosed |
| EP-2108642-A1 | JAK INHIBITOR | Kyowa Hakko Kirin Co., Ltd. (JP) | 2009-10-14 | — | — | EP | disclosed |
| WO-2008109333-A1 | INDOLE AND BENZOTHIOPHENE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11052377-B2 | Supported metal catalyst | SOD1, SOD3, SLC39A14 | MAPK14 1865/4885GHSR 4509/4885GPR183 3582/4885 |
| US-20110178062-A1 | INDOLE AND BENZOTHIOPHENE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR | HRH3, HRH4, HRH1 | MAPK14 2871/4885GHSR 508/4885GPR183 407/4885 |
| US-20200290018-A1 | SUPPORTED METAL CATALYST | SOD1, SOD3, SLC39A14 | MAPK14 1865/4885GHSR 4509/4885GPR183 3582/4885 |
| US-20150110809-A1 | MODULATORS OF EXCHANGE PROTEINS DIRECTLY ACTIVATED BY CAMP (EPACS) | RAPGEF3, RAPGEF4, CREB1 | MAPK14 1443/4885GHSR 1975/4885GPR183 1534/4885 |
| US-11345702-B1 | PGDH inhibitors and methods of making and using | HPGD, HPGDS, PTGS1 | MAPK14 2818/4885GHSR 1998/4885GPR183 1041/4885 |
| US-20150057248-A1 | BIVALENT AMPA RECEPTOR POSITIVE ALLOSTERIC MODULATORS | GRIK2, GABRE, GRIK4 | MAPK14 3269/4885GHSR 363/4885GPR183 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.